Articles and posts USelectAllNewsNeola Medical carries out a directed share issue of SEK 20 million and thereby secures financing for 2024December 13, 2023 | News, RegulatoryNeola Medical has been granted a patent in Europe for the company’s disposablesDecember 12, 2023 | News, Non regulatoryThe technical founder of Neola Medical at the Nobel Prize ceremony 2023December 11, 2023 | NewsNeola Medical AB starts a subsidiary in the USADecember 4, 2023 | News, Non regulatoryNeola Medical’s CEO tells more about the latest news in the investor letter for autumn 2023November 15, 2023 | News, Non regulatoryCEO Hanna Sjöström comments Q3 report 2023 in new article by BioStockNovember 14, 2023 | Articles, NewsCEO and CFO presents Q3 2023November 13, 2023 | News, PresentationsNeola Medical receives an award during this year’s NOME Annual Meeting in CopenhagenNovember 10, 2023 | NewsCEO Hanna Sjöström comments on the Q3 report 2023 in Nyhetsbyrån DirektNovember 9, 2023 | NewsNeola Medical Q3 report 2023 – Doors open in the U.S. with Stanford support and new strong final results from independent clinical trial in newbornsNovember 9, 2023 | News, RegulatoryNeola Medical invites to presentation of the Q3-report 2023November 2, 2023 | News, Non regulatoryThe business newspaper Rapidus draws attention to Neola Medical’s support from StanfordOctober 24, 2023 | News# 12345678910111213 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Neola Medical carries out a directed share issue of SEK 20 million and thereby secures financing for 2024December 13, 2023 | News, Regulatory
Neola Medical has been granted a patent in Europe for the company’s disposablesDecember 12, 2023 | News, Non regulatory
Neola Medical’s CEO tells more about the latest news in the investor letter for autumn 2023November 15, 2023 | News, Non regulatory
CEO Hanna Sjöström comments Q3 report 2023 in new article by BioStockNovember 14, 2023 | Articles, News
Neola Medical receives an award during this year’s NOME Annual Meeting in CopenhagenNovember 10, 2023 | News
Neola Medical Q3 report 2023 – Doors open in the U.S. with Stanford support and new strong final results from independent clinical trial in newbornsNovember 9, 2023 | News, Regulatory
The business newspaper Rapidus draws attention to Neola Medical’s support from StanfordOctober 24, 2023 | News